Vitamin D baseline levels at diagnosis of breast cancer: A systematic review and meta-analysis

Bandera Merchan, 2017, The role of vitamin D and VDR in carcinogenesis: through epidemiology and basic sciences, J Steroid Biochem Mol Biol, 167, 203, 10.1016/j.jsbmb.2016.11.020 Zhang, 2017, Influence of vitamin D signaling on hormone receptor status and HER2 expression in breast cancer, J Cancer Res Clin Oncol, 143, 1107, 10.1007/s00432-016-2325-y Fornes, 2020, JASPAR 2020: update of the open-access database of transcription factor binding profiles, Nucleic Acids Res, 48, D87 Shao, 2012, Vitamin D and breast cancer, Oncologist, 17, 36, 10.1634/theoncologist.2011-0278 Tomita, 2013, Mechanisms of action and resistance to all-trans retinoic acid (ATRA) and arsenic trioxide (As2O3) in acute promyelocytic leukemia, Int J Hematol, 97, 717, 10.1007/s12185-013-1354-4 Horas, 2019, Loss of the vitamin D receptor in human breast cancer cells promotes epithelial to mesenchymal cell transition and skeletal colonization, J Bone Mineral Res, 34, 1721, 10.1002/jbmr.3744 Forrest, 2011, Prevalence and correlates of vitamin D deficiency in US adults, Nutr Res, 359, 48, 10.1016/j.nutres.2010.12.001 Manousaki, 2017, Low vitamin D levels as a risk factor for cancer, Br Med J, 359 O’Brien, 2017, Serum vitamin D and risk of breast cancer within five years, Environ Health Perspect, 125, 10.1289/EHP943 Skaaby, 2014, Prospective population-based study of the association between serum 25-hydroxyvitamin-D levels and the incidence of specific types of cancer, Cancer Epidemiol Biomarkers Prev, 23, 1220, 10.1158/1055-9965.EPI-14-0007 Chlebowski, 2008, Calcium plus vitamin D supplementation and the risk of breast cancer, J Natl Cancer Inst, 100, 1581, 10.1093/jnci/djn360 Amir, 2012, 25-Hydroxy vitamin-D, obesity, and associated variables as predictors of breast cancer risk and tamoxifen benefit in NSABP-P1, Breast Cancer Res Treat, 133, 1077, 10.1007/s10549-012-2012-x Villaseñor, 2013, Associations of serum 25-hydroxyvitamin D with overall and breast cancer-specific mortality in a multiethnic cohort of breast cancer survivors, Cancer Causes Control, 24, 759, 10.1007/s10552-013-0158-4 Tommie, 2018, Serum vitamin D status and breast cancer risk by receptor status: a systematic review, Nutr Cancer, 70, 804, 10.1080/01635581.2018.1470653 Lope, 2018, Serum 25-hydroxyvitamin D and breast cancer risk by pathological subtype (MCC-Spain), J Steroid Biochem Mol Biol, 182, 4, 10.1016/j.jsbmb.2018.04.005 Higgins, 2003, Measuring inconsistency in meta-analyses, Br Med J, 327, 557, 10.1136/bmj.327.7414.557 Neyeloff, 2012, Meta-analyses and Forest plots using a Microsoft Excel spreadsheet: step-by-step guide focusing on descriptive data analysis, BMC Res Notes, 5, 52, 10.1186/1756-0500-5-52 Voutsadakis, 2017, A systematic review and pooled analysis of retrospective series of eribulin in metastatic breast cancer, Anticancer Drugs, 28, 557, 10.1097/CAD.0000000000000493 Wallace, 2009, Meta-Analyst: software for meta-analysis of binary, continuous and diagnostic data, BMC Med Res Methodol, 9, 80, 10.1186/1471-2288-9-80 Hayden, 2013, Assessing bias in studies of prognostic factors, Ann Intern Med, 158, 280, 10.7326/0003-4819-158-4-201302190-00009 Chiba, 2018, Serum vitamin D levels affect pathologic complete response in patients undergoing neoadjuvant systemic therapy for operable breast cancer, Clin Breast Cancer, 18, 144, 10.1016/j.clbc.2017.12.001 Yao, 2011, Pretreatment serum concentrations of 25-hydroxyvitamin D and breast cancer prognostic characteristics: a case-control and a case-series study, PLoS ONE, 6, 10.1371/journal.pone.0017251 Wu, 2017, Association of vitamin D3 level with breast cancer risk and prognosis in African-American and Hispanic women, Cancers, 9, 144, 10.3390/cancers9100144 Peppone, 2012, The association between breast cancer prognostic indicators and serum 25-OH vitamin D levels, Ann Surg Oncol, 19, 2590, 10.1245/s10434-012-2297-3 Matos Machado, 2019, Low pretreatment serum concentration of vitamin D at breast cancer diagnosis in postmenopausal women, Menopause, 26, 293, 10.1097/GME.0000000000001203 AlFaris, 2018, A descriptive study of vitamin D and other nutritional factors in breast cancer patients in Saudi Arabia, Saudi Med J, 39, 564, 10.15537/smj.2018.6.21902 Shaukat, 2017, Association between vitamin D deficiency and breast cancer, Pak J Med Sci, 33, 645, 10.12669/pjms.333.11753 Shirazi, 2016, Serum vitamin D (25OHD3) levels and the risk of different subtypes of breast cancer: a nested case-control study, Breast, 28, 184, 10.1016/j.breast.2016.06.002 Karthikayan, 2018, Low serum 25-hydroxyvitamin D levels are associated with aggressive breast cancer variants and poor prognostic factors in patients with breast carcinoma, Arch Endocrinol Metab, 62, 452, 10.20945/2359-3997000000062 Rainville, 2009, Triple negative breast cancer patients presenting with low serum vitamin D levels: a case series, Cases J, 2, 8390, 10.4076/1757-1626-2-8390 Hemida, 2019, Vitamin D receptor in breast cancer tissues and its relation to estrogen receptor alpha (ER-α) gene expression and serum 25-hydroxyvitamin D levels in Egyptian breast cancer patients: a case-control study, Clin Breast Cancer, 19, e407, 10.1016/j.clbc.2018.12.019 Lohmann, 2015, Prognostic associations of 25 hydroxy vitamin D in NCIC CTG MA.21, a phase III adjuvant randomized clinical trial of three chemotherapy regimens in high-risk breast cancer, Breast Cancer Res Treat, 150, 605, 10.1007/s10549-015-3355-x Hatse, 2012, Vitamin D status at breast cancer diagnosis: correlation with tumor characteristics, disease outcome, and genetic determinants of vitamin D insufficiency, Carcinogenesis, 33, 1319, 10.1093/carcin/bgs187 Goodwin, 2009, Prognostic effects of 25-hydroxyvitamin D levels in early breast cancer, J Clin Oncol, 27, 3757, 10.1200/JCO.2008.20.0725 Abulkhair, 2016, Vitamin D levels and breast cancer characteristics: findings in patients from Saudi Arabia, J Steroid Biochem Mol Biol, 164, 106, 10.1016/j.jsbmb.2015.11.003 de Sousa, 2017, Vitamin D deficiency is associated with poor breast cancer prognostic features in postmenopausal women, J Steroid Biochem Mol Biol, 174, 284, 10.1016/j.jsbmb.2017.10.009 Ismail, 2018, Prognostic significance of serum vitamin D levels in Egyptian females with breast cancer, Asian Pac J Cancer Prev, 19, 571 Buono, 2017, Pretreatment serum concentration of vitamin D and breast cancer characteristics: a prospective observational Mediterranean study, Clin Breast Cancer, 17, 559, 10.1016/j.clbc.2017.05.007 Crew, 2009, High prevalence of vitamin D deficiency despite supplementation in premenopausal women with breast cancer undergoing adjuvant chemotherapy, J Clin Oncol, 27, 2151, 10.1200/JCO.2008.19.6162 Kim, 2011, Vitamin D deficiency is correlated with poor outcomes in patients with luminal-type breast cancer, Ann Surg Oncol, 18, 1830, 10.1245/s10434-010-1465-6 Thanasitthichai, 2019, Negative impact of 25-hydroxyvitamin D deficiency on breast cancer survival, Asian Pac J Cancer Prev, 20, 3101, 10.31557/APJCP.2019.20.10.3101 Vashi, 2010, Impact of oral vitamin D supplementation on serum 25-hydroxyvitamin D levels in oncology, Nutr J, 9, 60, 10.1186/1475-2891-9-60 Viala, 2018, Impact of vitamin D on pathological complete response and survival following neoadjuvant chemotherapy for breast cancer: a retrospective study, BMC Cancer, 18, 770, 10.1186/s12885-018-4686-x Charehbili, 2016, Vitamin D (25-OH D3) status and pathological response to neoadjuvant chemotherapy in stage II/III breast cancer: data from the NEOZOTAC trial (BOOG 10–01), Breast, 25, 69, 10.1016/j.breast.2015.10.005 Kim, 2018, Association between changes in serum 25-hydroxyvitamin D levels and survival in patients with breast cancer receiving neoadjuvant chemotherapy, J Breast Cancer, 21, 134, 10.4048/jbc.2018.21.2.134 Clark, 2014, Pretreatment vitamin D level and response to neoadjuvant chemotherapy in women with breast cancer on the I-SPY trial (CALGB 150007/150015/ACRIN6657), Cancer Med, 3, 693, 10.1002/cam4.235 Welsh, 2011, Vitamin D metabolism in mammary gland and breast cancer, Mol Cell Endocrinol, 347, 55, 10.1016/j.mce.2011.05.020 Ditsch, 2012, The association between vitamin D receptor expression and prolonged overall survival in breast cancer, J Histochem Cytochem, 60, 121, 10.1369/0022155411429155 Yao, 2017, Association of serum level of vitamin D at diagnosis with breast cancer survival. A case-cohort analysis in the Pathways Study. JAMA, Oncol, 3, 351 Vrieling, 2011, Serum 25-hydroxyvitamin D and postmenopausal breast cancer survival: a prospective patient cohort study, Breast Cancer Res, 13, R74, 10.1186/bcr2920 O’Brien, 2019, The association of a breast cancer diagnosis with serum 25-hydroxyvitamin D concentration over time, Am J Epidemiol, 188, 637, 10.1093/aje/kwy285 Robsahm, 2013, The inverse relationship between 25-hydroxyvitamin D and cancer survival: discussion of causation, Cancers, 5, 1439, 10.3390/cancers5041439 Kanstrup, 2020, 25-hydroxyvitamin D at time of breast cancer diagnosis and breast cancer survival, Breast Cancer Res Treat, 179, 699, 10.1007/s10549-019-05486-4